Spectral molecular profiling is too complex to scale.
We make it autonomous.
Spectrometry is the foundational technology for modern analytical science. But today’s workflows remain highly manual, expert-dependent, and difficult to scale.
Modern spectrometers combine extraordinary sensitivity and resolution, allowing scientists to measure thousands of molecules across complex biological and environmental samples.
Powerful instruments still depend on fragile configurations. Choosing the right chromatography gradients, collision energies, and monitored transitions can take weeks, and each method must be re-optimized across instrument models, sample types, and experimental conditions.
From peak detection and integration to quantification, turning raw spectrometry signals into reliable quantitative data remains highly manual, operator-dependent, and difficult to reproduce at scale.
The complexity of spectrometry workflows still limits the reliability and scalability of molecular profiling across healthcare, biotech, pharma, CROs, and environmental testing.
Precision Medicine From metabolomics and proteomics to oncology biomarkers, pharmacokinetics, and clinical toxicology, spectral molecular profiling is becoming essential to modern medicine.
Consumer & Environmental Chemistry New regulatory pressure is creating urgent demand for scalable analytical testing in cosmetics, food, environmental, and consumer product sectors.
We make spectrometry autonomous.
MendAI Labs is building an AI agent, connected to scientific knowledge, that interacts with spectrometers in real time: configuring instruments, analyzing results, deciding when additional runs are needed, and quantifying the molecules present in complex samples.
PRISM
Turns raw spectrometry signals into reliable molecular concentrations.
HELIX
Continuously optimizes analytical methods through autonomous instrument control.
GENESIS
Turns biological questions into sample preparation protocols and analytical methods.
MendAI's machine learning-powered peak integration software
for LC-MS/MS and GC-MS workflows.
Unlike traditional rule-based software, Prism learns from operator corrections and continuously improves the reliability of peak integration across analytical batches.
MendAI Labs began when Guillaume and Paul met at Mila in 2025, united by a shared conviction: meaningful impact on patient health requires multidisciplinary expertise and a nuanced understanding of clinical needs. View our publications →
PhD | Co-founder & CEO
Mila · Université de Montréal · École polytechnique Paris
Completed his PhD at Mila under the supervision of Prof. Yoshua Bengio, focusing on modelling cellular responses to biological perturbations. His work included an iterative experimental design approach prospectively validated with a chemical biology team, as well as an interpretable generative model for large-scale omics data.
The scientific foundations of MendAI’s AI solutions build directly on this expertise at the intersection of deep learning and biology.
PharmD, PhD | Co-founder & CSO
AP-HP · Sorbonne Université · Mila
Spent eight years as a hospital practitioner at the Paris university hospitals and Sorbonne University. He led translational research initiatives within the spectrometry platform at Saint-Antoine Hospital, and developed innovative diagnostic tests integrating machine learning and spectrometry.
This dual clinical and scientific expertise underpins the medical relevance and real-world applicability of MendAI's solutions.
Jacques Corbeil
Professor of Medicine, Research Chair in Medical Genomics
Alexandre Le Bouthillier
Member of the Mila Board of Directors, Investor & Entrepreneur
Sorbonne Université
Partner institution for Prism validation & clinical research expertise
Mila
Incubated by Mila Ventures, with access to offices, compute resources, and expert advisors.
Whether you operate a spectrometry platform, work in healthcare, pharma, research, or industrial testing, or are exploring strategic partnerships, we’d love to hear from you.
contact@mendailabs.com